GRDN — Guardian Pharmacy Services, Inc.
—
NYSE ·
Consumer Staples ·
Drug Retail ·
CIK 1802255 ·
Last close
$41.21
Market Cap
$2.05B
52W High
$48.33
52W Low
$23.14
ADV30
587,780
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 351,768,000 | 80,044,000 | 20,644,000 | 21,872,000 | 443,578,000 | 89,807,000 | 185,936,000 |
| Mar 2026 | 336,595,000 | 76,309,000 | 17,675,000 | 13,295,000 | 426,941,000 | 64,893,000 | 194,517,000 |
| Dec 2025 | 397,616,000 | 85,502,000 | 30,762,000 | 20,923,000 | 412,658,000 | 65,619,000 | 194,734,000 |
| Sep 2025 | 377,427,000 | 74,721,000 | 16,354,000 | 9,818,000 | 390,037,000 | 36,487,000 | 194,540,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$98,856,000
Investing CF
$-22,732,000
Financing CF
$-5,134,000
CapEx
$-19,071,000
Dividends Paid
$0
Buybacks
$-30,276,000
EPS Diluted TTM
$1.03
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$101,510,000
Inventory
$50,442,000
Receivables
$103,769,000
ST Investments
—
EBIT TTM
$96,446,000
Pretax Income TTM
$95,815,000
Interest Exp TTM
$631,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,463,405,952
EBITDA
$109,406,000
Free Cash Flow
$64,545,500
Enterprise Value
$2,725,748,224
Total Cash
$89,807,000
Total Debt
$39,268,000
Shares Out
49,798,904
Trailing EPS
$1.04
Book Value
$3.88
ROE
30.4%
ROA
13.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,448,685,000 | 72,701,000 | 49,219,000 | 412,658,000 | 194,734,000 | 205,759,000 | 100,255,000 |
| Dec 2024 | 1,228,409,000 | -62,920,000 | -87,287,000 | 320,810,000 | 170,834,000 | 142,671,000 | 57,960,000 |
| Dec 2023 | 1,046,193,000 | 40,946,000 | 23,902,000 | 271,165,000 | 211,306,000 | 0 | 70,819,000 |
| Dec 2022 | 908,909,000 | 51,990,000 | 35,421,000 | 256,114,000 | 180,185,000 | 0 | 48,522,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.43
Max Pain — expiry 2027-01-15
max pain strike: $30.00 · spot: $41.22 · call oi: 888 · put oi: 142
Expected Move to 2027-01-15:
±$8.75
(21.23%) —
implied range
$32.47 –
$49.97
· ATM straddle on $40.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CVS | CVS HEALTH Corp | $113.99B | $89.13 | — |
| PETS | PETMED EXPRESS INC | $33.17M | $1.53 | — |
| YI | 111, Inc. | $18.71M | $3.60 | — |
| RDGT | Ridgetech Inc. | $3.01M | $0.83 | — |
| CANN | TREES Corp (Colorado) | — | $nan | — |
News headlines (Yahoo Finance, 1h cache)
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
2026-09-01 20:30 · Yahoo
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
2026-08-13 23:44 · Yahoo
Why Guardian Pharmacy Services (GRDN) Is Up 10.9% After Raising 2026 Revenue Guidance And Expanding Footprint
2026-08-08 22:11 · Yahoo
Guardian Pharmacy Services Q2 Earnings Call Highlights
2026-08-08 10:03 · Yahoo
Guardian Pharmacy Services Raises 2026 Outlook After Strong Second Quarter
2026-08-07 12:46 · Yahoo
Guardian Pharmacy Services Inc (GRDN) (Q2 2026) Earnings Call Highlights: Raised Guidance and ...
2026-08-07 05:06 · Yahoo
Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates
2026-08-06 23:10 · Yahoo
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
2026-07-15 20:30 · Yahoo
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
2026-06-29 09:51 · Yahoo
Guardian Pharmacy Services, Inc. Announces Leadership Transitions
2026-06-22 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.